The UK continues to be at the forefront globally of innovation in medical research and clinical trials for the development of new treatments and medicines for cancer patients. Clinical research and medical trials are a vital part of the cancer treatment development process, and it is only through the continued commitment of patients and research funders, such as the NHS, research charities and global pharmaceutical companies, that crucial progress can continue to be made.

The Government has committed to continuing its support by increasing the share of GDP spent on research and development to 2.4% by 2027 and to 3% by 2030.

In this blog we detail links to some of the latest research in mesothelioma and current clinical trials.

 

How common is mesothelioma?

Every year around 2,700 people are diagnosed with mesothelioma.

Mesothelioma in the chest (pleural mesothelioma) is much more common than mesothelioma in the abdomen (peritoneal mesothelioma).

 

Who gets mesothelioma?

Due to the most common cause of this disease being exposure to asbestos at work, Mesothelioma is more common in men than women. Typically, workers from industrial, shipping, factory working environments were the most at risk.

It is more common in older people. In the UK, on average each year, 55 out of 100 (55%) people diagnosed are aged 75 and over.

 

Mesothelioma research

Researchers are looking at the causes, diagnosis, and treatment of mesothelioma.

You can visit the Cancer Research UK’s clinical trials database if you are looking for a trial for mesothelioma in the UK. You need to talk to your specialist if there are any trials that you think you might be able to take part in.

Some of the clinical trials for Mesothelioma detailed on Cancer Research UK include:

A study looking at new tests to find out the different causes of disease of the lining of the lungs

Cancer type: Blood cancers; Hodgkin lymphoma; Lung cancer; Lymphoma; Mesothelioma; Non small cell lung cancer; Non-Hodgkin lymphoma; Small cell lung cancer

A study collecting information about people with mesothelioma of the lung (ASSESS-meso)

Cancer type: Lung cancer; MesotheliomaThis study is looking at scans, blood tests and lung fluid tests to improve diagnosis for people with fluid in the lung lining (pleural effusion), or thickening of the lung lining

Sources: Cancer Research UK, Link: Mesothelioma Research, Accessed February 2023

 

Industrial Disease Specialists

Larcomes Solicitors have specialist asbestos disease accreditation from the Association of Personal Injury Lawyers (APIL) and an expert team who deal solely with Asbestos injury claims.

For further information and resources on cancer clinical trials you can visit our information page: Cancer Trials and Research

If you would like to discuss your asbestos- related disease claim with us, then give us a call on 023 9244 8100 and we will be happy to talk with you or please contact us online.